Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Lucie Bartova

Biographic Data

ID7654110
NAMELucie Bartova
GIVEN NAMESLucie
FAMILY NAMEBartova
SIGNATUREBARTOVA L
AFFILIATIONSMedical University of Vienna
ORCID0000-0002-1769-8025
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Ketamine for negative and depressive symptoms in schizophrenia

    Open Access•C M Diendorfer, C Bum et al.•ARTICLE•Frontiers in Psychiatry•2026

    Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…

  • Case report

    Open Access•Maximilian Preiß, Ulrich Rabl et al.•ARTICLE•Frontiers in Psychiatry•2023

    The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portra…

  • Case report

    Open Access•Victoria Watzal, Godber Mathis Godbersen et al.•ARTICLE•Frontiers in Psychiatry•2023

    The second-generation anticonvulsant lamotrigine is widely used in the psychiatric field as a mood stabilizer or antidepressant augmentation therapy. Although particularly older anticonvulsants are known for their potential to cause hypersensitivity syndromes, newer antiepileptic drugs do hold a certain risk as well. Presenting a case of a 32-year-old male inpatient of African ethnicity suffering from a primary severe depressive episode in the co…

  • The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol

    Open Access•Marleen Margret Mignon Swoboda, Lucie Bartova et al.•ARTICLE•Frontiers in Psychiatry•2022

    QT interval prolongation and ventricular tachyarrhythmia are potential adverse effects of antidepressant (AD) and antipsychotic- (AP) agents, especially when overdosed. Since AD and AP agents are often prescribed to patients suffering from suicidal intentions, it is essential to estimate these risks in the context of intoxications. This retrospective and naturalistic one-year registry study included 105 patients treated for oral intoxication at t…

  • Case Report

    Open Access•Ivan Milenković, Lucie Bartova et al.•ARTICLE•Frontiers in Psychiatry•2021

    The diagnosis of parkinsonian syndromes in patients with severe depression may be challenging due to overlapping clinical phenomena, especially regarding psychomotor and affective symptoms. [ 123 I]FP-CIT-SPECT is a useful method to detect degenerative parkinsonian disorders. However, some drugs may influence the tracer binding and thus alter the result. We present a case of 56-year-old female inpatient with difficult-to-treat late-onset depressi…

No prominent works on this page.

  • Case Report

    Open Access•Ivan Milenković, Lucie Bartova et al.•ARTICLE•Frontiers in Psychiatry•2021

    The diagnosis of parkinsonian syndromes in patients with severe depression may be challenging due to overlapping clinical phenomena, especially regarding psychomotor and affective symptoms. [ 123 I]FP-CIT-SPECT is a useful method to detect degenerative parkinsonian disorders. However, some drugs may influence the tracer binding and thus alter the result. We present a case of 56-year-old female inpatient with difficult-to-treat late-onset depressi…

  • The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol

    Open Access•Marleen Margret Mignon Swoboda, Lucie Bartova et al.•ARTICLE•Frontiers in Psychiatry•2022

    QT interval prolongation and ventricular tachyarrhythmia are potential adverse effects of antidepressant (AD) and antipsychotic- (AP) agents, especially when overdosed. Since AD and AP agents are often prescribed to patients suffering from suicidal intentions, it is essential to estimate these risks in the context of intoxications. This retrospective and naturalistic one-year registry study included 105 patients treated for oral intoxication at t…

  • Case report

    Open Access•Maximilian Preiß, Ulrich Rabl et al.•ARTICLE•Frontiers in Psychiatry•2023

    The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portra…

  • Case report

    Open Access•Victoria Watzal, Godber Mathis Godbersen et al.•ARTICLE•Frontiers in Psychiatry•2023

    The second-generation anticonvulsant lamotrigine is widely used in the psychiatric field as a mood stabilizer or antidepressant augmentation therapy. Although particularly older anticonvulsants are known for their potential to cause hypersensitivity syndromes, newer antiepileptic drugs do hold a certain risk as well. Presenting a case of a 32-year-old male inpatient of African ethnicity suffering from a primary severe depressive episode in the co…

  • Ketamine for negative and depressive symptoms in schizophrenia

    Open Access•C M Diendorfer, C Bum et al.•ARTICLE•Frontiers in Psychiatry•2026

    Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…

Medicine (4 works) · Psychiatry (4 works) · Antidepressant (3 works) · Internal Medicine (3 works) · Psychology (3 works) · Antipsychotic (2 works) · Anxiety (2 works) · Depression (economics (2 works) · Epilepsy research and treatment (2 works) · Pharmacology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae